Role of endoscopy in predicting the disease course in inflammatory bowel disease

被引:76
作者
Allez, Matthieu [1 ,2 ]
Lemann, Marc [1 ,2 ]
机构
[1] Univ Paris 07, Hop St Louis, APHP, Dept Gastroenterol, F-75010 Paris, France
[2] Univ Paris 07, Hop St Louis, APHP, Equipe AVENIR INSERM, F-75010 Paris, France
关键词
Crohn's disease; Ulcerative colitis; Inflammatory bowel disease; Colonoscopy; Natural history; Outcome; Medical therapy; Surgery; ACTIVE ULCERATIVE-COLITIS; RELEASE ORAL MESALAMINE; CROHNS-DISEASE; MAINTENANCE THERAPY; INFLIXIMAB; AZATHIOPRINE; SEVERITY; MANAGEMENT; REMISSION; ATTACKS;
D O I
10.3748/wjg.v16.i21.2626
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Endoscopy provides a direct evaluation of mucosal lesions in inflammatory bowel disease (IBD), permitting the description of elementary lesions, their surface extent and severity. The severity of mucosal lesions directly reflects disease activity and may help to identify an aggressive behavior of the disease. Several studies have recently pointed out the potential role of endoscopy in the prediction of IBD outcome. Indeed, severe endoscopic lesions in Crohn's disease (CD) patients, defined by deep and extensive ulcerations on at least one part of the colon, are associated with an increased risk of penetrating complication and surgery. Severe endoscopic lesions during severe attacks of ulcerative colitis (UC) are associated with an increased risk of colectomy in the short and long term. Severity of postoperative recurrence in CD may help to predict the risk of clinical relapse and need for further surgery. Achievement of mucosal healing, which can be obtained by administration of several types of drugs, is associated with a better outcome, less surgery and hospitalization. This review focuses on the assessment of endoscopic severity in CD and UC and on the impact of endoscopic severity on disease outcome. More specifically, we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt treatment strategies. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:2626 / 2632
页数:7
相关论文
共 45 条
[1]
Allez M, 2002, AM J GASTROENTEROL, V97, P947
[2]
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis [J].
Ardizzone, S ;
Maconi, G ;
Russo, A ;
Imbesi, V ;
Colombo, E ;
Porro, GB .
GUT, 2006, 55 (01) :47-53
[3]
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease [J].
Baert, Filip ;
Moortgat, Liesbeth ;
Van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
De Vos, Martine ;
Stokkers, Pieter ;
Hommes, Daniel ;
Rutgeerts, Paul ;
Vermeire, Severine ;
D'Haens, Geert .
GASTROENTEROLOGY, 2010, 138 (02) :463-468
[4]
Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].
Baert, FJ ;
D'Haens, GR ;
Peeters, M ;
Hiele, MI ;
Schaible, TF ;
Shealy, D ;
Geboes, K ;
Rutgeerts, PJ .
GASTROENTEROLOGY, 1999, 116 (01) :22-28
[5]
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations [J].
Caprilli, R ;
Gassull, MA ;
Escher, JC ;
Moser, G ;
Munkholm, P ;
Forbes, A ;
Hommes, DW ;
Lochs, H ;
Angelucci, E ;
Cocco, A ;
Vucelic, B ;
Hildebrand, H ;
Kolacek, S ;
Riis, L ;
Lukas, M ;
de Franchis, R ;
Hamilton, M ;
Jantschek, G ;
Michetti, P ;
O'Morain, C ;
Anwar, MM ;
Freitas, JL ;
Mouzas, IA ;
Baert, F ;
Mitchel, R ;
Hawkey, CJ .
GUT, 2006, 55 :i36-i58
[6]
COLONOSCOPY OF ACUTE COLITIS - A SAFE AND RELIABLE TOOL FOR ASSESSMENT OF SEVERITY [J].
CARBONNEL, F ;
LAVERGNE, A ;
LEMANN, M ;
BITOUN, A ;
VALLEUR, P ;
HAUTEFEUILLE, P ;
GALIAN, A ;
MODIGLIANI, R ;
RAMBAUD, JC .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) :1550-1557
[7]
Carbonnel F, 2000, ALIMENT PHARM THERAP, V14, P273
[8]
CORRELATIONS BETWEEN CLINICAL ACTIVITY, ENDOSCOPIC SEVERITY, AND BIOLOGICAL PARAMETERS IN COLONIC OR ILEOCOLONIC CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY OF 121 CASES [J].
CELLIER, C ;
SAHMOUD, T ;
FROGUEL, E ;
ADENIS, A ;
BELAICHE, J ;
BRETAGNE, JF ;
FLORENT, C ;
BOUVRY, M ;
MARY, JY ;
MODIGLIANI, R ;
COLOMBEL, JF ;
CORTOT, A ;
LESCUT, D ;
BITOUN, A ;
LEMANN, M ;
SALMERON, M ;
THEROND, JP ;
VERNISSE, B ;
SEE, A ;
RAOUL, JL .
GUT, 1994, 35 (02) :231-235
[9]
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease. [J].
Colombel, Jean Frederic ;
Sandborn, William J. ;
Reinisch, Walter ;
Mantzaris, Gerassimos J. ;
Kornbluth, Asher ;
Rachmilewitz, Daniel ;
Lichtiger, Simon ;
D'Haens, Geert ;
Diamond, Robert H. ;
Broussard, Delma L. ;
Tang, Kezhen L. ;
van der Woude, C. Janneke ;
Rutgeerts, Paul .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) :1383-1395
[10]
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].
D'Haens, G ;
Van Deventer, S ;
Van Hogezand, R ;
Chalmers, D ;
Kothe, C ;
Baert, F ;
Braakman, T ;
Schaible, T ;
Geboes, K ;
Rutgeerts, P .
GASTROENTEROLOGY, 1999, 116 (05) :1029-1034